COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 484: Articles 4831-4840  | Next

Time series analysis of routine immunisation coverage during the COVID-19 pandemic in 2021 shows continued global decline and increases in Zero Dose children
Evans, B., Keiser, O., Kaiser, L., Jombart, T.
10.1101/2023.02.06.23285411 — Posted: 2023-02-08
Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022
Varkila, M., Montez-Rath, M., Salomon, J., Yu, X., Block, G., Owens, D., Chertow, G., Parsonnet, J., Anand, S.
10.1101/2023.02.06.23285542 — Posted: 2023-02-08
Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profiling
Beisenova, A., Adi, W., Bashar, S. J., Velmurugan, M., Germanson, K. B., Shelef, M. A., Yesilkoy, F.
10.1101/2023.02.06.23285535 — Posted: 2023-02-08
Characteristics of COVID-19 in children and potential risk factors for requiring mechanical ventilation; an analysis of 22,490 cases from the United States
Verma, R., Ramphul, K., Lohana, P., Sombans, S., Ramphul, Y., Pekyi-Boateng, P. K. K.
10.1101/2023.02.06.23285543 — Posted: 2023-02-08
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China
Wang, X., Jiang, S., Jiang, S., Li, X., Ai, J., Lin, K., Lv, S., Zhang, S., Li, M., He, X., Li, D., Li, C., Zhao, C., Zhao, X., Qiao, R., Cui, Y., Chen, Y., Li, J., Cai, G., Li, J., Dai, L., Hu, Z., Zhang, W., Zhang, Y., Wang, P.
10.1101/2023.02.07.527406 — Posted: 2023-02-07
Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates
Chea, C., Lee, D.-Y., Kato, J., Ishiwata-Endo, H., Moss, J.
10.1101/2023.02.07.527501 — Posted: 2023-02-07
Longitudinal changes in IgG-type SARS-CoV-2 antibody titers after COVID-19 vaccination and, prominent increase in antibody titers when infected after vaccination
Kusunoki, H., Ohkusa, M., Iida, R., Saito, A., Kawahara, M., Ekawa, K., Kato, N., Yamasaki, K., Motone, M., Shimizu, H.
10.1101/2023.02.04.23285414 — Posted: 2023-02-07
Rapid prototyping of models for COVID-19 outbreak detection in workplaces
Abell, I., Zachreson, C., Conway, E., Geard, N., McVernon, J., Waring, T., Baker, C.
10.1101/2023.02.05.23285483 — Posted: 2023-02-07
Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features
Martelloni, G., Turchi, A., Fallerini, C., Degl'Innocenti, A., Baldassarri, M., GEN-COVID Multicenter study, , Olmi, S., Furini, S., Renieri, A.
10.1101/2023.02.06.527291 — Posted: 2023-02-07
A Bayesian inference method to estimate transmission trees with multiple introductions; applied to SARS-CoV-2 in Dutch mink farms.
Van der Roest, B. R., Bootsma, M., Fischer, E., Klinkenberg, D., Kretzschmar, M.
10.1101/2023.02.07.527429 — Posted: 2023-02-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).